Rapid and Sustained Decline in CXCL-10 (IP-10) Annotates Clinical Outcomes Following TNF-α Antagonist Therapy in Hospitalized Patients with Severe and Critical COVID-19 Respiratory Failure

Category Primary study
JournalOpen Forum Infectious Diseases
Year 2021
This article has no abstract
Epistemonikos ID: 05fb1fbb68532a959ed07b2b72be75fb8f24d7e9
First added on: Feb 13, 2025